Literature DB >> 19049886

A modified fast (4 day) 96-well plate Caco-2 permeability assay.

Masashi Uchida1, Tominaga Fukazawa, Yuri Yamazaki, Hisashi Hashimoto, Yohei Miyamoto.   

Abstract

INTRODUCTION: The Caco-2 permeability assay is widely used for lead optimization in drug discovery. A 3 to 5-day system using a 24-well plate and a 10 to 21-day system using a 96-well plate have been established. Here, we modified the assay system to provide a ready-to-use Caco-2 cell monolayer using a 96-well plate in just 4 days. METHODS AND
RESULTS: In our system, collagen-coated inserts and the prolongation of the culture period after seeding leads to greater Caco-2 cell proliferation and sufficient contact-inhibition. The differentiation of Caco-2 cells was enhanced, when the contact-inhibited Caco-2 cells were exposed to the differentiation-inducing agent butyric acid. The permeability to nine well-known compounds showed a statistical correlation between our 4-day system using a 96-well plate and the conventional 21-day system using a 24-well plate. DISCUSSION: We conclude that our system is more useful for evaluating many compounds for lead optimization in drug discovery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049886     DOI: 10.1016/j.vascn.2008.10.006

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  14 in total

1.  Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties.

Authors:  David Bruhn; Dora B Madhura; Marcus Maddox; Robin B Lee; Ashit Trivedi; Lei Yang; Michael S Scherman; Janet C Gilliland; Veronica Gruppo; Michael R McNeil; Anne J Lenaerts; Bernd Meibohm; Richard E Lee
Journal:  Bioorg Med Chem       Date:  2012-08-28       Impact factor: 3.641

2.  Sensing of barrier tissue disruption with an organic electrochemical transistor.

Authors:  Scherrine A Tria; Marc Ramuz; Leslie H Jimison; Adel Hama; Roisin M Owens
Journal:  J Vis Exp       Date:  2014-02-10       Impact factor: 1.355

3.  In silico model for P-glycoprotein substrate prediction: insights from molecular dynamics and in vitro studies.

Authors:  Rameshwar Prajapati; Udghosh Singh; Abhijeet Patil; Kailas S Khomane; Pravin Bagul; Arvind K Bansal; Abhay T Sangamwar
Journal:  J Comput Aided Mol Des       Date:  2013-04-24       Impact factor: 3.686

4.  Permeability of rhynchophylline across human intestinal cell in vitro.

Authors:  Bo Ma; Jing Wang; Jing Sun; Ming Li; Huibo Xu; Guibo Sun; Xiaobo Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

5.  Preclinical studies of YK-4-272, an inhibitor of class II histone deacetylases by disruption of nucleocytoplasmic shuttling.

Authors:  Hye-Sik Kong; Shuo Tian; Yali Kong; Guanhua Du; Li Zhang; Mira Jung; Anatoly Dritschilo; Milton L Brown
Journal:  Pharm Res       Date:  2012-07-27       Impact factor: 4.200

6.  Identification and Characterization of CINPA1 Metabolites Facilitates Structure-Activity Studies of the Constitutive Androstane Receptor.

Authors:  Milu T Cherian; Lei Yang; Sergio C Chai; Wenwei Lin; Taosheng Chen
Journal:  Drug Metab Dispos       Date:  2016-08-12       Impact factor: 3.922

7.  Validated HPLC Method for Concurrent Determination of Antipyrine, Carbamazepine, Furosemide and Phenytoin and its Application in Assessment of Drug Permeability through Caco-2 Cell Monolayers.

Authors:  Sachin Ramrao Patil; Lokesh Kumar; Gunjan Kohli; Arvind Kumar Bansal
Journal:  Sci Pharm       Date:  2011-10-22

8.  Preclinical studies of the potent and selective nicotinic α4β2 receptor ligand VMY-2-95.

Authors:  Hyesik Kong; Jun-ke Song; Venkata Mahidhar Yenugonda; Li Zhang; Tian Shuo; Amrita K Cheema; Yali Kong; Guan-hua Du; Milton L Brown
Journal:  Mol Pharm       Date:  2015-01-20       Impact factor: 4.939

9.  The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  PeerJ       Date:  2015-11-17       Impact factor: 2.984

Review 10.  Fitting Transporter Activities to Cellular Drug Concentrations and Fluxes: Why the Bumblebee Can Fly.

Authors:  Pedro Mendes; Stephen G Oliver; Douglas B Kell
Journal:  Trends Pharmacol Sci       Date:  2015-11-01       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.